talidomida accord 50 mg
idifarma desarrollo farmaceutico s.l. - spania - talidomidum - caps. - 50mg - imunosupresoare alte imunosupresoare
kesimpta
novartis ireland ltd - ofatumumab - scleroză multiplă, scleroză multiplă recurent-remisivă - immunosuppressant - kesimpta is indicated for the treatment of adult patients with relapsing forms of multiple sclerosis (rms) with active disease defined by clinical or imaging features (see section 5.
lenalidomida terapia 10 mg
sun pharmaceutical industries europe b.v. - olanda - lenalidomidum - caps. - 10mg - imunosupresoare alte imunosupresoare
lenalidomida terapia 15 mg
sun pharmaceutical industries europe b.v. - olanda - lenalidomidum - caps. - 15mg - imunosupresoare alte imunosupresoare
lenalidomida terapia 20 mg
sun pharmaceutical industries europe b.v. - olanda - lenalidomidum - caps. - 20mg - imunosupresoare alte imunosupresoare
lenalidomida terapia 5 mg
sun pharmaceutical industries europe b.v. - olanda - lenalidomidum - caps. - 5mg - imunosupresoare alte imunosupresoare
lenalidomida terapia 7,5 mg
sun pharmaceutical industries europe b.v. - olanda - lenalidomidum - caps. - 7,5mg - imunosupresoare alte imunosupresoare
thalidomide lipomed
lipomed gmbh - thalidomide - mielom multiplu - imunosupresoare - thalidomide lipomed in combination with melphalan and prednisone is indicated as first line treatment of patients with untreated multiple myeloma, aged ≥ 65 years or ineligible for high dose chemotherapy. thalidomide lipomed is prescribed and dispensed in accordance with the thalidomide lipomed pregnancy prevention programme (see section 4.
briumvi
neuraxpharm pharmaceuticals s.l. - ublituximab - multiple sclerosis, relapsing-remitting; multiple sclerosis - imunosupresoare - briumvi is indicated for the treatment of adult patients with relapsing forms of multiple sclerosis (rms) with active disease defined by clinical or imaging features.
zalmoxis
molmed spa - alogen t celule modificate genetic cu un vector retrovirale codificarea pentru o formă trunchiată a receptorilor de factor de creştere nervos uman afinitate scăzută (Δlngfr) si herpes simplex virus timidin chinază (hsv tk mut2) - hematopoietic stem cell transplantation; graft vs host disease - agenți antineoplazici - zalmoxis este indicat ca tratament adjuvant în transplantul de celule stem hematopoietice haploidentic (hsct) de pacienţi adulţi cu tumori maligne hematologice cu risc ridicat.